Anacor Drug Patent Portfolio
Anacor owns 2 orange book drugs protected by 19 US patents Given below is the list of Anacor's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8168614 | Boron-containing small molecules as anti-inflammatory agents | 20 Jul, 2030 | Active |
| US8168614 | Boron-containing small molecules as anti-inflammatory agents | 20 Jan, 2030 | Active |
| US8039451 | Boron-containing small molecules | 29 Dec, 2029 | Active |
| US8039451 | Boron-containing small molecules | 29 Jun, 2029 | Active |
| US7582621 | Boron-containing small molecules | 26 Nov, 2027 | Active |
| US8501712 | Boron-containing small molecules as anti-inflammatory agents | 16 Aug, 2027 | Active |
| US9682092 | Boron-containing small molecules as anti-inflammatory agents | 16 Aug, 2027 | Active |
| US7582621 | Boron-containing small molecules | 26 May, 2027 | Active |
| US7767657 | Boron-containing small molecules | 22 May, 2027 | Active |
| US8501712 | Boron-containing small molecules as anti-inflammatory agents | 16 Feb, 2027 | Active |
| US9682092 | Boron-containing small molecules as anti-inflammatory agents | 16 Feb, 2027 | Active |
| US9549938 | Boron-containing small molecules | 16 Aug, 2026 | Active |
| US9566289 | Boron-containing small molecules | 16 Aug, 2026 | Active |
| US9566290 | Boron-containing small molecules | 16 Aug, 2026 | Active |
| US9572823 | Boron-containing small molecules | 16 Aug, 2026 | Active |
| US9549938 | Boron-containing small molecules | 16 Feb, 2026 | Expired |
| US9566289 | Boron-containing small molecules | 16 Feb, 2026 | Expired |
| US9566290 | Boron-containing small molecules | 16 Feb, 2026 | Expired |
| US9572823 | Boron-containing small molecules | 16 Feb, 2026 | Expired |
Latest Legal Activities on Anacor's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Anacor.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Expire Patent | 31 Mar, 2025 | US9572823 |
| Expire Patent | 24 Mar, 2025 | US9566290 |
| Expire Patent | 24 Mar, 2025 | US9566289 |
| Expire Patent | 03 Mar, 2025 | US9549938 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 03 Jan, 2025 | US8501712 |
| Withdrawal of Application for PTE | 18 Dec, 2024 | US7582621 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 14 Nov, 2024 | US9682092 |
| Maintenance Fee Reminder Mailed | 14 Oct, 2024 | US9572823 |
| Maintenance Fee Reminder Mailed | 07 Oct, 2024 | US9566290 |
| Maintenance Fee Reminder Mailed | 07 Oct, 2024 | US9566289 |
| Maintenance Fee Reminder Mailed | 16 Sep, 2024 | US9549938 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 12 Oct, 2023 | US8168614 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 09 Mar, 2023 | US8039451 |
| Application Return TO OIPE | 18 Jul, 2022 | US9566290 |
|
Correspondence Address Change
Critical
| 18 Jul, 2022 | US9566290 |
Anacor's Drug Patent Litigations
Anacor's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Aug 20, 2015, against patent number US7767657. The petitioner Coalition for Affordable Drugs X, LLC, challenged the validity of this patent, with Anacor Pharmaceuticals, Inc. as the respondent. Click below to track the latest information on how companies are challenging Anacor's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US9549938 | November, 2017 |
Final Written Decision
(05 Jun, 2019)
| Anacor Pharmaceuticals, Inc. et al. | FlatWing Pharmaceuticals, LLC et al. |
| US9566289 | November, 2017 |
Final Written Decision
(05 Jun, 2019)
| Anacor Pharmaceuticals, Inc. et al. | FlatWing Pharmaceuticals, LLC et al. |
| US9566290 | November, 2017 |
Final Written Decision
(05 Jun, 2019)
| Anacor Pharmaceuticals, Inc. et al. | FlatWing Pharmaceuticals, LLC et al. |
| US9572823 | November, 2017 |
Final Written Decision
(05 Jun, 2019)
| Anacor Pharmaceuticals, Inc. et al. | FlatWing Pharmaceuticals, LLC et al. |
| US9549938 | July, 2018 |
Terminated
(11 Oct, 2018)
| Pfizer Inc. | Mylan Pharmaceuticals Inc. et al. |
| US9566289 | July, 2018 |
Terminated
(11 Oct, 2018)
| Pfizer Inc. | Mylan Pharmaceuticals Inc. et al. |
| US9566290 | July, 2018 |
Terminated
(11 Oct, 2018)
| Pfizer Inc. | Mylan Pharmaceuticals Inc. et al. |
| US9572823 | July, 2018 |
Terminated
(11 Oct, 2018)
| Pfizer Inc. | Mylan Pharmaceuticals Inc. et al. |
| US7582621 | August, 2015 |
Final Written Decision
(23 Feb, 2017)
| Anacor Pharmaceuticals, Inc. | Coalition for Affordable Drugs X LLC |
| US7767657 | August, 2015 |
Final Written Decision
(23 Feb, 2017)
| Anacor Pharmaceuticals, Inc. | Coalition for Affordable Drugs X, LLC |
Anacor's Family Patents
Anacor Drug List
Given below is the complete list of Anacor's drugs and the patents protecting them.
1. Eucrisa
Eucrisa is protected by 8 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8168614
(Pediatric)
| Boron-containing small molecules as anti-inflammatory agents |
20 Jul, 2030
(4 years from now)
| Active |
| US8168614 | Boron-containing small molecules as anti-inflammatory agents |
20 Jan, 2030
(3 years from now)
| Active |
| US8039451
(Pediatric)
| Boron-containing small molecules |
29 Dec, 2029
(3 years from now)
| Active |
| US8039451 | Boron-containing small molecules |
29 Jun, 2029
(3 years from now)
| Active |
| US8501712
(Pediatric)
| Boron-containing small molecules as anti-inflammatory agents |
16 Aug, 2027
(1 year, 4 months from now)
| Active |
| US9682092
(Pediatric)
| Boron-containing small molecules as anti-inflammatory agents |
16 Aug, 2027
(1 year, 4 months from now)
| Active |
| US8501712 | Boron-containing small molecules as anti-inflammatory agents |
16 Feb, 2027
(10 months from now)
| Active |
| US9682092 | Boron-containing small molecules as anti-inflammatory agents |
16 Feb, 2027
(10 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Eucrisa's drug page
2. Kerydin
Kerydin is protected by 11 patents, out of which 4 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7582621
(Pediatric)
| Boron-containing small molecules |
26 Nov, 2027
(1 year, 8 months from now)
| Active |
| US7582621 | Boron-containing small molecules |
26 May, 2027
(1 year, 2 months from now)
| Active |
| US7767657 | Boron-containing small molecules |
22 May, 2027
(1 year, 2 months from now)
| Active |
| US9549938
(Pediatric)
| Boron-containing small molecules |
16 Aug, 2026
(4 months from now)
| Active |
| US9566289
(Pediatric)
| Boron-containing small molecules |
16 Aug, 2026
(4 months from now)
| Active |
| US9566290
(Pediatric)
| Boron-containing small molecules |
16 Aug, 2026
(4 months from now)
| Active |
| US9572823
(Pediatric)
| Boron-containing small molecules |
16 Aug, 2026
(4 months from now)
| Active |
| US9549938 | Boron-containing small molecules |
16 Feb, 2026
(a month ago)
| Expired |
| US9566289 | Boron-containing small molecules |
16 Feb, 2026
(a month ago)
| Expired |
| US9566290 | Boron-containing small molecules |
16 Feb, 2026
(a month ago)
| Expired |
| US9572823 | Boron-containing small molecules |
16 Feb, 2026
(a month ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Kerydin's drug page